EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Daily Zinc Supplementation for Infection Prevention in Children With Sickle Cell Anemia

Ruth Namazzi, Kagan A Mellencamp, Irene Bagala, Andrea L Conroy, Charles Kato, Isaac Birungi, Priscilla Kasembo, Gloria Kyarisiima, Emmanuel Tenywa, Jie Ren, Michael J Goings, Sarah E Cusick und 1 weitere

JAMA · 2026

DOI: 10.1001/jama.2026.14190 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA, 2026. Verfasst von Ruth Namazzi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Dietary Supplements, Infections, Zinc Sulfate. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Despite existing prevention strategies, infections remain a major cause of morbidity and mortality in children in Africa with sickle cell anemia.

Objective

To determine the safety and effectiveness of daily zinc supplementation to prevent all-cause infection in children with sickle cell anemia in Uganda. Design, Setting, and Participants A randomized, double-blind, placebo-controlled trial of children aged 1.00 to 4.99 years with sickle cell anemia at Jinja Regional Referral Hospital in Jinja, Uganda, from February 10, 2025, to April 30, 2025, with 6 months of follow-up through November 7, 2025.

Interventions

Participants received zinc sulfate at 20 mg daily or placebo daily for 6 months. Main Outcomes and Measures The primary outcome was all-cause infections per 100 person-years, using standardized clinical criteria to define infections.

Results

Among 118 children screened for eligibility, 100 were randomly assigned to receive zinc supplementation (n = 50) or placebo (n = 50) (mean [SD] age, 36.0 [13.2] months; 45 female [45%]). At enrollment, 45 participants (45%) were receiving hydroxyurea therapy. All participants initiated or continued receiving hydroxyurea after enrollment. During the 6-month follow-up, there was complete ascertainment for all participants and no loss to follow-up. There were 80 all-cause infections in the zinc group and 124 in the placebo group, corresponding to a significantly lower infection rate in the zinc group than the placebo group (305.7 [95% CI, 242.4-380.4] infections per 100 person-years vs 480.7 [95% CI, 399.8-573.1] infections per 100 person-years; rate difference, −176.0 [95% CI, −300.8 to −51.3]; incidence rate ratio after adjustment for baseline age, sex, and hydroxyurea use, 0.62 [95% CI, 0.45-0.86]). No adverse events requiring discontinuation of the study intervention were observed in either group. Conclusions and Relevance Zinc supplementation at 20 mg per day reduced all-cause infection in children with sickle cell anemia younger than 5 years in Uganda. Multisite clinical trials are needed to validate these findings and to assess effectiveness in older children. Trial Registration ClinicalTrials.gov Identifier: NCT06561061

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellDietary SupplementsInfectionsZinc SulfateChild, PreschoolFemaleHumansInfantMaleDouble-Blind MethodUgandaHydroxyureaFollow-Up StudiesIncidence

Substanzen

Zinc SulfateHydroxyurea

Autor:innen und Institutionen

  • Department of Pediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda.
  • Global Health Uganda, Kampala, Uganda.
  • Ryan White Center for Pediatric Infectious Diseases and Global Health, Department of Pediatrics, Indiana University School of Medicine, Indianapolis.
  • Nalufenya Children's Hospital, Jinja Regional Referral Hospital, Jinja, Uganda.
  • Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis.
  • Department of Pediatrics, University of Minnesota Medical School, Minneapolis.

Zitieren

APA

Namazzi, R., Mellencamp, K. A., Bagala, I., Conroy, A. L., Kato, C., Birungi, I., Kasembo, P., Kyarisiima, G., Tenywa, E., Ren, J., Goings, M. J., Cusick, S. E., & John, C. C. (2026). Daily Zinc Supplementation for Infection Prevention in Children With Sickle Cell Anemia. JAMA. https://doi.org/10.1001/jama.2026.14190

Vancouver

Namazzi R, Mellencamp KA, Bagala I, Conroy AL, Kato C, Birungi I, et al. Daily Zinc Supplementation for Infection Prevention in Children With Sickle Cell Anemia. JAMA. 2026. doi:10.1001/jama.2026.14190

BibTeX
@article{Namazzi2026,
  author = {Namazzi, Ruth and Mellencamp, Kagan A and Bagala, Irene and Conroy, Andrea L and Kato, Charles and Birungi, Isaac and Kasembo, Priscilla and Kyarisiima, Gloria and Tenywa, Emmanuel and Ren, Jie and Goings, Michael J and Cusick, Sarah E and John, Chandy C},
  title = {Daily Zinc Supplementation for Infection Prevention in Children With Sickle Cell Anemia},
  journal = {JAMA},
  year = {2026},
  doi = {10.1001/jama.2026.14190}
}
Kostenlos starten →